IDENTIFICATION DE LYMPHOCYTES CD8+ QUI ONT UNE EXPRESSION ÉLEVÉE DE CD161 (CD161HI) ET/OU DE IL18R (ALPHA) (IL18R (ALPHA)HI) ET QUI ONT UNE CAPACITÉ D'ÉCOULEMENT DE MÉDICAMENT RAPIDE
This invention provides, among other things, methods for the identification and isolation of viable putative long-lived antigen-specific memory CD8+ T cell subsets (CMhi and EMhi) with high surface expression of CD161 and/or IL-18Ra and the capacity to rapidly efflux the fluorescent dye Rh123.